Deerfield Private Design Fund III, L.P., 10% Owner at ARS Pharmaceuticals, Inc. (SPRY), sold 598,084 shares at $17.45 ($10.8M) on 2024-11-11, disclosed to the SEC on 2024-11-13.
Open-market sale of $10.8M SPRY by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.45 | 40,596 | $708K | 6.6% |
| 2 | $17.45 | 40,596 | $708K | 6.6% |
| 3 | $18.15 | 223,632 | $4.1M | 37.7% |
| 4 | $18.15 | 223,632 | $4.1M | 37.7% |
| 5 | $17.16 | 7,853 | $135K | 1.3% |
| 6 | $17.16 | 7,853 |
| $135K |
| 1.3% |
| 7 | $17.16 | 7,854 | $135K | 1.3% |
| 8 | $17.16 | 7,854 | $135K | 1.3% |
| 9 | $17.77 | 9,553 | $170K | 1.6% |
| 10 | $17.77 | 9,553 | $170K | 1.6% |
| 11 | $17.77 | 9,554 | $170K | 1.6% |
| 12 | $17.77 | 9,554 | $170K | 1.6% |
| Total | $17.98 avg | 598,084 | $10.8M | 100% |
| Filing → |
| ALIM | BUY | 2015-10-29 | $89K | — | Filing → |